Issue 29 - The Cancer Letter

<img class="lazy" src="data:image/svg+xml,%3Csvg%20xmlns='http://www.w3.org/2000/svg'%20viewBox='0%200%201%201'%3E%3C/svg%3E" data-src="https://cdn.cancerletter.com/media/2021/03/17053004/TCL-logo-horizontal-white.png" alt="" >

Vol.

37

No.

29

July 22, 2011Jul 22, 2011

Free

DOWNLOAD THE PDF

A Year at NCI: Harold Varmus Reflects On Provocative Questions, The Duke Scandal, Financial Disaster And Grant Review

Part One Of A Two-Part Interview With NCI Director Harold Varmus

Also: NCCN Committee Reaffirms Clinical Guideline Covering Avastin for Breast Cancer Indication

ODAC Votes For Accelerated Approval For Adcetris For Two Lymphoma Indications

Richard Pazdur’s Comments to ODAC

Department of Defense Offering $16 Million in Cancer Research Grants

Recent Issues

Volume 52 | Issue 05 - February 06, 2026

Volume 52 | Issue 04 - January 30, 2026

Volume 52 | Issue 03 - January 23, 2026

Volume 52 | Issue 02 - January 16, 2026

Volume 52 | Issue 1 - January 09, 2026

Volume 51 | Issue 46 - December 19, 2025